New cancer drug combo tested in tiny trial – but halted early
Disease control
Terminated
This early-stage trial tested an experimental drug called BND-35, alone or combined with nivolumab or cetuximab, in 12 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose. The study was te…
Phase: PHASE1 • Sponsor: Biond Biologics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC